Chemed (CHE) Long-Term Investments (2009 - 2026)

Chemed's Long-Term Investments history runs 18 years deep, the most recent figure standing at $143.8 million for Q1 2026.

• In Q1 2026, Long-Term Investments rose 12.37% year-over-year to $143.8 million; the TTM figure through Mar 2026 stood at $143.8 million (up 12.37% YoY), while the FY2025 annual figure was $140.3 million, up 7.17% from the prior year.
• Long-Term Investments was $143.8 million for Q1 2026 at Chemed, up from $140.3 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $143.8 million in Q1 2026 to a low of $90.1 million in Q3 2022.
• Historically, Long-Term Investments has averaged $115.3 million across 5 years, with a median of $117.6 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Long-Term Investments dropped 11.71% in 2022, then rose 23.4% in 2024.
• A 5-year view of Long-Term Investments shows it stood at $93.2 million in 2022, then gained by 13.87% to $106.1 million in 2023, then advanced by 23.4% to $131.0 million in 2024, then rose by 7.17% to $140.3 million in 2025, then increased by 2.44% to $143.8 million in 2026.
• The last three Long-Term Investments figures came in at $143.8 million (Q1 2026), $140.3 million (Q4 2025), and $136.0 million (Q3 2025), per Business Quant data.